| [1] |
罗恒聪，张莹．妊娠期高血糖胰岛素应用的种类、特点和技巧[J/CD]．中华产科急救电子杂志，2021，10(1)：20-24.
|
| [2] |
Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U．S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research [J]. Ann Intern Med, 2013, 159(2)：123-129.
|
| [3] |
Society of Maternal-Fetal Medicine (SMFM) Publications Committee. SMFM statement: pharmacological treatment of gestational diabetes [J]. Am J Obstet Gynecol, 2018, 218(5)：B2-B4.
|
| [4] |
Kumar R, Lowe J, Thompson-Hutchison F, et al. Implementation and Evaluation of the " Metformin First" Protocol for Management of Gestational Diabetes [J]. Can J Diabetes, 2019, 43(8)：554-559.
|
| [5] |
Camelo Castillo W, Boggess K, Stürmer T, et al. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol [J]. 2014, 123(6)：1177-1184.
|
| [6] |
Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus [J]. N Engl J Med. 2000, 343(16)：1134-1138.
|
| [7] |
Brown J, Martis R, Hughes B, et al. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes [J]. Cochrane Database Syst Rev, 2017, 1(1)：CD011967.
|
| [8] |
National Collaborating Centre for Women′s and Children′s Health (UK). Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period [M]. London, National Collaborating Centre for Women′s and Children′s Health (UK), 2015. PMID: 25950069.
|
| [9] |
Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care [J]. Int J Gynaecol Obstet, 2015，131 Suppl 3: S173-211.
|
| [10] |
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus [J]. Obstet Gynecol, 2018，131(2): e49-e64.
|
| [11] |
American Diabetes Association. 13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2018 [J]. Diabetes Care, 2018, 41(Suppl 1): S137-S143.
|
| [12] |
Doi SAR, Furuya-Kanamori L, Toft E, et al. Metformin in pregnancy to avert gestational diabetes in women at high risk: meta-analysis of randomized controlled trials [J]. Obes Rev, 2020, 21(1)：e12964.
|
| [13] |
Balsells M, García-Patterson A, Solà I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis [J]. BMJ, 2015, 350: h102.
|
| [14] |
Butalia S, Gutierrez L, Lodha A, et al. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis [J]. Diabet Med, 2017, 34(1)：27-36.
|
| [15] |
Feig DS, Donovan LE, Zinman B, et al. MiTy Collaborative Group. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial [J]. Lancet Diabetes Endocrinol, 2020, 8(10)：834-844.
|
| [16] |
Glueck CJ, Pranikoff J, Aregawi D, et al. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome [J]. FertilSteril, 2008, 89(3)：625-634.
|
| [17] |
Vanky E, Stridsklev S, Heimstad R，et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study [J]. J Clin Endocrinol Metab, 2010, 95(12)：E448-455.
|
| [18] |
Syngelaki A, Nicolaides KH, Balani J, et al. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus [J]. N Engl J Med, 2016, 374(5)：434-443.
|
| [19] |
Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial [J]. Lancet Diabetes Endocrinol, 2015, 3(10)：778-786.
|
| [20] |
Brownfoot FC, Hastie R, Hannan NJ, et al. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction [J]. Am J Obstet Gynecol, 2016, 214(3)：356.e1-356.e15.
|
| [21] |
Vanky E, Zahlsen K, Spigset O, et al. Placental passage of metformin in women with polycystic ovary syndrome [J]. FertilSteril, 2005, 83(5)：1575-1578.
|
| [22] |
Jiang S, Teague AM, Tryggestad JB, et al. Role of metformin in epigenetic regulation of placental mitochondrial biogenesis in maternal diabetes [J]. Sci Rep, 2020, 10(1)：8314.
|
| [23] |
Forcato S, Montagnini BG, de Góes MLM, et al. Reproductive evaluations in female rat offspring exposed to metformin during intrauterine and intrauterine/lactational periods [J]. Reprod Toxicol, 2019, 87：1-7.
|
| [24] |
Rowan JA, Rush EC, Obolonkin V, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age [J]. Diabetes Care, 2011, 34(10)：2279-2284.
|
| [25] |
Wouldes TA, Battin M, Coat S, et al. Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes [J]. Arch Dis Child Fetal Neonatal Ed，101(6)：F488-F493.
|
| [26] |
Maple-Brown LJ, Lindenmayer G, Barzi F, et al. Northern Territory Diabetes in Pregnancy Partnership. Real-world experience of metformin use in pregnancy: Observational data from the Northern Territory Diabetes in Pregnancy Clinical Register [J]. J Diabetes, 2019, 11 (9)：761-770.
|
| [27] |
Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes [J]. N Engl J Med, 2008, 358(19): 2003-2015.
|
| [28] |
Song R, Chen L, Chen Y, et al. Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis [J]. PLoS One, 2017, 12(8)：e0182488.
|
| [29] |
Sénat MV, Affres H, Letourneau A，et al. Groupe de Recherche enObstétrique et Gynécologie (GROG). Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: a randomized clinical trial [J]. JAMA, 2018, 319(17)：1773-1780.
|
| [30] |
Harper LM, Glover AV, Biggio JR, et al. Predicting failure of glyburide therapy in gestational diabetes [J]. J Perinatol, 2016, 36(5)：347-351.
|
| [31] |
Schwartz RA, Rosenn B, Aleksa K, et al. Glyburide transport across the human placenta [J]. Obstet Gynecol, 2015, 125(3)：583-588.
|
| [32] |
Coustan DR. Pharmacological management of gestational diabetes: an overview [J]. Diabetes Care, 2007, 30 Suppl 2: S206-S208.
|
| [33] |
Chan LY, Yeung JH, Lau TK. Placental transfer of rosiglitazone in the first trimester of human pregnancy [J]. FertilSteril, 2005, 83(4): 955-958.
|
| [34] |
Nachum Z, Zafran N, Salim R, et al. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study [J]. Diabetes Care, 2017, 40(3): 332-337.
|
| [35] |
Farrar D, Simmonds M, Bryant M, et al. Treatments for gestational diabetes: a systematic review and meta-analysis [J]. BMJ Open, 2017, 7(6)：e015557.
|